Perfuze, a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke, has been granted Breakthrough Device Designation by the U.S. FDA for its Millipede CIS
The post Perfuze receives breakthrough device designation status from FDA for Millipede CIS appeared first on NS Medical Devices.